GRANITE POINT CAPITAL MANAGEMENT, L.P. Medicenna Therapeutics Corp. Transaction History

GRANITE POINT CAPITAL MANAGEMENT, L.P. portfolio value:

$270,000
portfolio value

Medicenna Therapeutics Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 325K shares 270K $0.83 325K